M. Fava

4.7k total citations
12 papers, 1.0k citations indexed

About

M. Fava is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Clinical Psychology. According to data from OpenAlex, M. Fava has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Experimental and Cognitive Psychology and 3 papers in Clinical Psychology. Recurrent topics in M. Fava's work include Treatment of Major Depression (8 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers) and Bipolar Disorder and Treatment (2 papers). M. Fava is often cited by papers focused on Treatment of Major Depression (8 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers) and Bipolar Disorder and Treatment (2 papers). M. Fava collaborates with scholars based in United States, Italy and Canada. M. Fava's co-authors include J F Rosenbaum, Roy H. Perlis, Jerrold F. Rosenbaum, A. John Rush, Madhukar H. Trivedi, Stephen R. Wisniewski, Dan V. Iosifescu, Vivian S. Gainer, Jordan W. Smoller and Caitlin C. Clements and has published in prestigious journals such as BMJ, Acta Psychiatrica Scandinavica and Journal of Psychiatric Research.

In The Last Decade

M. Fava

12 papers receiving 963 citations

Peers

M. Fava

PHARM

PMH

CP

ECP

CCM

John Tiller Australia

Kurt Bjerregaard Stage Denmark

Shamsah B. Sonawalla United States

Emanuela Offidani Italy

Bill Lyndon Australia

Rajinder Judge United States

James G. Barbee United States

P.M.J. Haffmans Netherlands

Salem Bensasi United States

Robert Barnes United States

John Tiller Australia

M. Fava

352 ×1.0

PHARM

449 ×1.3

PMH

287 ×1.1

CP

212 ×1.0

ECP

113 ×0.7

CCM

Citations per year, relative to M. Fava M. Fava (= 1×) peers John Tiller

Countries citing papers authored by M. Fava

Since Specialization

Citations

This map shows the geographic impact of M. Fava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Fava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Fava more than expected).

Fields of papers citing papers by M. Fava

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Fava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Fava. The network helps show where M. Fava may publish in the future.

Co-authorship network of co-authors of M. Fava

This figure shows the co-authorship network connecting the top 25 collaborators of M. Fava. A scholar is included among the top collaborators of M. Fava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Fava. M. Fava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Fava, M., Bryan Dirks, Richard C. Shelton, et al.. (2019). P.032 A phase-2, double-blind, placebo-controlled, sequential parallel comparison design study of efficacy and safety of adjunctive pimavanserin in major depressive disorder. European Neuropsychopharmacology. 29. S42–S43. 1 indexed citations

2.

Castro, Víctor M., Caitlin C. Clements, Sue Murphy, et al.. (2013). QT interval and antidepressant use: a cross sectional study of electronic health records. BMJ. 346(jan29 3). f288–f288. 187 indexed citations

3.

Perlis, Roy H., M. Fava, Madhukar H. Trivedi, et al.. (2009). Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder. Acta Psychiatrica Scandinavica. 119(4). 282–289. 80 indexed citations

4.

Fava, M., et al.. (2008). A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. Journal of Psychopharmacology. 22(8). 843–848. 63 indexed citations

5.

Gaynes, Bradley N., A. John Rush, Madhukar H. Trivedi, et al.. (2007). Major Depression Symptoms in Primary Care and Psychiatric Care Settings: A Cross-Sectional Analysis. The Annals of Family Medicine. 5(2). 126–134. 84 indexed citations

6.

Fava, M., Michael J. Detke, Matteo Balestrieri, et al.. (2006). Management of depression relapse: Re-initiation of duloxetine treatment or dose increase. Journal of Psychiatric Research. 40(4). 328–336. 22 indexed citations

7.

Papakostas, George I., Thor Petersen, Alistair Burns, & M. Fava. (2005). Adjunctive atomoxetine for residual fatigue in major depressive disorder. Journal of Psychiatric Research. 40(4). 370–373. 23 indexed citations

8.

Fava, M.. (2000). Weight gain and antidepressants.. PubMed. 61 Suppl 11. 37–41. 289 indexed citations

9.

Fava, M.. (2000). New approaches to the treatment of refractory depression.. PubMed. 61 Suppl 1. 26–32. 83 indexed citations

10.

Fava, M. & J F Rosenbaum. (1999). Anger attacks in patients with depression.. PubMed. 60 Suppl 15. 21–4. 98 indexed citations

11.

Fava, M. & Jerrold F. Rosenbaum. (1998). Anger attacks in depression. Depression and Anxiety. 8(S1). 59–63. 52 indexed citations

12.

Otto, Michael W., et al.. (1994). Norms for depressed patients for the California verbal learning test: Associations with depression severity and self-report of cognitive difficulties. Archives of Clinical Neuropsychology. 9(1). 81–88. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact